Literature DB >> 8158031

Immunity to onchocerciasis: identification of a putatively immune population in a hyperendemic area of Ecuador.

L H Elson1, R H Guderian, E Araujo, J E Bradley, A Days, T B Nutman.   

Abstract

The existence of immunity to Onchocerca volvulus (Ov) infection is suggested by the presence of uninfected persons in hyperendemic areas. A major barrier to the study of immunity has been the correct identification of putatively immune (PI) subjects. To identify a PI group in a hyperendemic area in Ecuador, clinical and epidemiologic information was combined with a polymerase chain reaction (PCR)-based assay identifying Ov DNA in skin snips and a recombinant antigen-based ELISA. Comparison of immune responses revealed that PI subjects had significantly lower levels of Ov-specific IgG, IgG subclasses, and IgE than infected (INF) subjects. Female subjects were significantly more likely to be PI than male subjects, and INF female subjects had significantly lower levels of Ov-specific IgG, IgG1, and IgG3 than INF male subjects. Thus, the use of molecular-based techniques has helped to define more precisely the PI state in onchocerciasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158031     DOI: 10.1093/infdis/169.3.588

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Immunoglobulin kappa chain allotypes (KM) in onchocerciasis.

Authors:  J P Pandey; L H Elson; S E Sutherland; R H Guderian; E Araujo; T B Nutman
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 2.  Pathogenesis of onchocercal keratitis (River blindness).

Authors:  L R Hall; E Pearlman
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

3.  Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.

Authors:  A A Gbakima; T B Nutman; J E Bradley; L A McReynolds; M D Winget; Y Hong; A L Scott
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 4.  Recent advances in tropical medicine.

Authors:  D N Lockwood; G Pasvol
Journal:  BMJ       Date:  1994-06-11

5.  Population biology of human onchocerciasis.

Authors:  M G Basáñez; M Boussinesq
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

6.  Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans.

Authors:  James S McCarthy; Moira Wieseman; Joe Tropea; David Kaslow; David Abraham; Sara Lustigman; Rocky Tuan; Ronald H Guderian; Thomas B Nutman
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

7.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis.

Authors:  M J Taylor; N Abdel-Wahab; Y Wu; R E Jenkins; A E Bianco
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infection.

Authors:  Peter D Burbelo; Roshan Ramanathan; Amy D Klion; Michael J Iadarola; Thomas B Nutman
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.